Dr. Ajmer Singh Grewal

Professor & Head, Department of Pharmaceutical Chemistry

Guru Gobind Singh College of Pharmacy, Yamunanagar, Haryana, India

Dr. Ajmer Singh Grewal is a leading Indian pharmaceutical scientist and educator with over 13 years of academic and research experience. His work spans the entire spectrum of medicinal chemistry, drug discovery, synthetic chemistry, and computational drug design, contributing extensively to academia, research, and the pharmaceutical sciences community.

1. Ph.D. in Pharmaceutical Sciences

I.K. Gujral Punjab Technical University, Jalandhar

Research Focus: Glucokinase Activators for Type 2 Diabetes

2. M. Pharmacy (Pharmaceutical Chemistry) 

Biju Patnaik University of Technology, Orissa

3. B. Pharmacy 

Kurukshetra University, Haryana

Computational Chemistry:

1. Expertise in ligand- and structure-based drug design

2. Extensive use of: AutoDock, MOE, PyMOL, Schrodinger Suite, SwissADME, pkCSM

3. Targets: EGFR, HDAC, PARP, MMP-9, NDM-1, PPARδ, GKRP, Aldose Reductase, PDE4/7

Synthetic Chemistry:

1. Synthesized heterocyclic scaffolds: Benzamides, Triazoles, Thiazolidines, Oxadiazoles, Benzothiazoles

2. Evaluated for: Antidiabetic, Anti-inflammatory, Antimicrobial, Anti-cancer properties

Analytical Chemistry:

1. Skilled in IR, NMR, MS

2. Instruments handled: FTIR, UV-Vis, HPLC, Flash Chromatography

• HOD, Department of Pharmaceutical Chemistry

• Led NAAC & NBA documentation and accreditation tasks

• Coordinator for Add-on Skill Development Programs

• Academic Planner, Faculty Advisor, Committee Chair

• Citations - 3,297

• h-index - 23

• i10-index - 53

• Total Publications  -121+

• Books & Chapters - 21 Books, 26 Chapters

• Patents - 6 (3 Granted)

• Cumulative Impact - 175+

1. Drug Design & Development – R. Narain Publishers, 2019

2. Emerging Approaches in Anti-Diabetic Drug Discovery – Lambert, 2022

3. Novel Molecular Targets in Drug Design – Edu-Spread, 2022

4. Advances in Pharmaceutical Research – NOVA Science, 2022

5. Research Advances in Biomedical Sciences – GGSCOP, 2023

6. Natural Products in Drug Development – NOVA Science, 2023

7. Innovations in Herbal Drug Development – NOVA Science, 2023

8. Emerging Trends in Pharmacognosy – GGSCOP, 2023

9. Advances in Biomaterials – Elsevier (Woodhead), 2023

10. Therapeutics in Neurological Disorders – NOVA Science, 2024

11. Translational Chemistry & Drug Discovery – IGI Global, 2024

12. Green Chemistry for Drug Design – IGI Global, 2024

13. Innovative Phytopharmaceutical Research – NOVA Science, 2024

14. Recent Trends in Drug Discovery – NOVA Science, 2024

15. Biologically Active Compounds – NOVA Science, 2024

16. Plant-Based Drug Delivery Systems – NOVA Science, 2025

17. Phytoconstituents & Cancer Therapy – NOVA Science, 2025

(+4 More in editorial process)

2024 – Latest Contributions

1. Sulfamoyl Benzamides as Allosteric Activators of Human Glucokinase

2. Marine-Derived Compounds for Alzheimer’s Therapy

3. Nanoformulated Dual PARP-Tubulin Inhibitors in Cancer Therapy

4. Therapeutic Potential of Quercetin: A Clinical Perspective

5. Comprehensive Review on Terminalia chebula

2023 – Advances in Drug Design & Phytochemistry

1. Cinnamic Acid Derivatives as Anticancer Agent

2. Therapeutic Role of Nrf2 in Liver Disorders

3. Yucca gloriosa Constituents for Asthma Inhibition

4. Quercetin-Loaded Nanoparticles for Cancer Management

2022 – Antidiabetic and Antimicrobial Innovations

1. GPR-40 Agonists for Type 2 Diabetes

2. New Delhi Metallo-β-Lactamase-1 Inhibitors

3. Anti-Liver Disease Molecules via PDE4 Inhibition

4. Nanotechnology in Nutraceuticals

2021 – Multifunctional Molecular Designs

1. Thiazolidine Derivatives as PDE4/7 Inhibitors

2. Natural Compounds as Aldose Reductase Inhibitors

3. Bioactivity of Benzothiazole Benzamide Derivatives

4. Streptomyces in Drug Discovery

 2017–2020 – Core Therapeutic Contributions

1. Pyrazole Carboxamides as Anti-Alzheimer’s Agents

2. PPARδ Agonists from Benzamide Scaffolds

3. Caffeic Acid Derivatives as MMP-9 Inhibitors

4. Nanomedicine-Based Products: Current Scenario

Research Highlights Summary

• 120+ Publications

• Journals Indexed in Scopus, Web of Science, and PubMed

• Collaborations with global researchers from IITs, NIPER, and international labs

Focused on: Diabetes, Inflammation, Antimicrobial Resistance, Neurodegeneration, Cancer

Ph.D. (5 Total)

• Awarded: 2 (NDM-1, Glucokinase Activators)

• Guiding: 3 (PDE7 Inhibitors, GPR120 Agonists, FBPase Inhibitors)

M. Pharmacy Thesis (9 Guided)

Topics include:

• PPARδ Agonists

• Triazole & Benzamide Derivatives

• MMP-9, PDE-4/7 Inhibitors

• Nanoformulations & Herbal Drug Systems

1. Top 2% Scientist – Stanford University (2023, 2024)

2. Young Scientist Award – Pharma Summit, 2022

3. Best Innovative Teacher – Pharma Lok, 2023

4. Excellence in Research – Chitkara University, 2019

5. Microsoft AI for Health Grant – ₹15L+ worth Azure credits

6. IGI Global Scientific Ambassador

7. Bentham Science Ambassador (2019–2025)

1. ISTE, APTI, PTRF, FHER, ERDA (Life Member)

2. Editorial Boards:

3. Scientific Reports (Springer)

4. Journal of Diabetes Research (Wiley)

5. BioMed Research International

6. Frontiers in Chemistry, Nutrition, Pain Research